Data / Form D filings / ViralClear Pharmaceuticals, Inc.
ViralClear Pharmaceuticals, Inc.: Form D filings
ViralClear Pharmaceuticals, Inc., a health care company in Westport, CT, filed 4 Form D notices with the SEC between 2019 and 2020. The latest, on June 3, 2020, reports $10.8 million sold of a $25 million offering to 81 investors.
Find out what ViralClear Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 54 WILTON ROAD, 2ND FLOOR, Westport, CT, 06880
- Phone
- (203) 409-5444
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1783807
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2020 | New notice | $25,000,000 | $10,751,250 | $14,248,750 | 81 | May 20, 2020 | sec.gov |
| Nov 5, 2019 | New notice | $20,000,000 | $686,370 | $19,313,630 | 8 | Oct 21, 2019 | sec.gov |
| Sep 9, 2019 | New notice | $160,000 | $160,000 | $0 | 1 | Sep 5, 2019 | sec.gov |
| Aug 20, 2019 | New notice | $3,600,000 | $3,260,000 | $340,000 | 17 | Aug 5, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dennis Purcell | Director | |
| Samuel Navarro | Director | |
| Anthony Zook | Director | |
| Nick Spring | Executive Officer, Director | |
| Steve Chaussy | Executive Officer | |
| Kenneth Londoner | Director | |
| Jeffrey O'Donnell | Director | |
| Michael Dougherty | Director | |
| Jerome Zeldis | Director | |
| Steven King | Executive Officer | |
| Natasha Drapeau | Director |
Other health care companies in Connecticut that filed recently
- Lift Managing Partners LLC offering · Nov 5, 2026
- Pantera, Inc. $4.1 million · Nov 2, 2026
- Oxbridge Health, Inc. $38.5 million · Aug 20, 2026
Every Form D from the week of Jun 1, 2020 · All recent filings in Connecticut · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what ViralClear Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.